WebNov 8, 2024 · Dual antiplatelet therapy (DAPT), including a P2Y12 inhibitor and aspirin, is the mainstay of treatment after percutaneous coronary intervention (PCI). Allergic reactions, intolerance, and hypersensitivity along with resistance are the drawbacks of aspirin therapy that led to the investigation of alternative pharmacological agents 1,2,3 . WebApr 16, 2024 · The latest guidelines recommend dual antiplatelet therapy (DAPT) with aspirin and clopidogrel for the first 3 to 6 months, followed by aspirin alone lifelong. 7, 8 Small underpowered randomized trials …
Dual Antiplatelet Therapy and ASA Allergy: What Do You …
WebApr 27, 2024 · DAPT with aspirin and ticagrelor or clopidogrel given within 24 hours of high-risk TIA or noncardioembolic mild to moderate stroke … WebApr 8, 2024 · Additional support for DAPT after ischemic stroke comes from CHANCE (Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack) in which patients with high-risk TIA and low NIHSS stroke were treated with clopidogrel load in the first 24 hours followed by DAPT for 21 days versus aspirin alone. 5 At 90 days, the … northeastern override
Dual Antiplatelet Therapy Versus Aspirin in Patients With …
WebDec 15, 2010 · Dual antiplatelet therapy (i.e., aspirin and clopidogrel) is mandatory after acute coronary syndrome or stent implantation because coronary lesions and stents behave like unstable plaques as long... WebApr 27, 2024 · DAPT with aspirin and ticagrelor or clopidogrel given within 24 hours of high-risk TIA or noncardioembolic mild to moderate stroke effectively reduces the risk of … WebMay 1, 2024 · aspirin 300 mg orally if they do not have dysphagia or aspirin 300 mg rectally or by enteral tube if they do have dysphagia. Continue aspirin daily 300 mg until 2 weeks after the onset of stroke symptoms, at which time start definitive long-term antithrombotic treatment. northeastern out of state acceptance rate